MarketsSingle-source
2.1
Handelsbanken maintains buy rating on Traton despite record share price
Dagens IndustriLO·SE · DE·2 days ago
SEB has increased its price target for Hansa Biopharma to 150 SEK, representing a 388% premium over the previous closing price. The bank cites a favorable risk-reward profile for the company's future development, though the extreme target suggests high volatility or a specific valuation model shift.